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Abstract
Background: Chimera proteins are widely used for the analysis of the protein-protein interaction
region. One of the major issues is the epitope analysis of the monoclonal antibody. In the analysis,
a continuous portion of an antigen is sequentially substituted into a different sequence. This method
works well for an antibody recognizing a linear epitope, but not for that recognizing a discontinuous
epitope. Although the designing the chimera proteins based on the tertiary structure information
is required in such situations, there is no appropriate tool so far.
Results: In light of the problem, we developed a tool named TCP (standing for a Tool for designing
Chimera Proteins), which extracts some sets of mutually orthogonal cutting surfaces for designing
chimera proteins using a genetic algorithm. TCP can also incorporate and consider the solvent
accessible surface area information calculated by a DSSP program. The test results of our method
indicate that the TCP is robust and applicable to various shapes of proteins.
Conclusion: We developed TCP, a tool for designing chimera proteins based on the tertiary
structure information. TCP is robust and possesses several favourable features, and we believe it
is a useful tool for designing chimera proteins. TCP is freely available as an additional file of this
manuscript for academic and non-profit organization.
Background
Chimera proteins are widely used for the analysis of the
protein-protein interaction region. One of the major
issues is the epitope analysis of the monoclonal antibody,
and there are conventional methods for the analysis. The
prediction of the epitopes in silico is convenient and var-
ious algorithms are developed so far. Most of these pro-
grams use primary sequence information and properties
of amino acid residues [1-6], and therefore, they are appli-
cable to the prediction of the continuous linear epitopes.
Recently, Moreau et al. proposed the PEPOP which
searches the candidates of peptide antigens using tertiary
structure information [7]. Many useful antibodies recog-
nize tertiary structures, i.e. the discontinuous epitopes,
and algorithms which predict the discontinuous ones are
required. To address the problem, some algorithms, e.g.
CEP [8], DiscoTope [9] and PEPITO [10], are developed.
On the other hand, there are also experimental methods
for the epitope analysis, e.g. parallel peptide syntheses
[11] and peptide arrays [12]. A well-established method is
a phage display [13,14]. This method uses a large size of a
peptide library which is presented on a phage protein. The
phage clones in the library which have high affinities for
the antibody of interest are selected and concentrated iter-
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obtained peptide sequences are analyzed, and several
methods for the data analysis are developed so far [15-
20]. Another common method is the use of chimera pro-
teins [21-23]. Lekcharoensuk et al. used the chimera pro-
teins of the type 2 (PCV2) and the type 1 (PCV1) porcine
circovirus capsid protein to determine the epitopes for the
monoclonal antibodies for the PCV2 [22], and School-
meester et al. used the human-mouse chimera proteins of
integrin α2 I-domain for the anti-human integrin α2 I-
domain antibody [23]. Although they used only primary
sequence information, Karisola et al. used the tertiary
structure information to design the hevein-AMP chimera
proteins for the epitope mapping of an allergen [21]. A
typical example of how to use of the chimera proteins is
described below. For example, an antibody assumes to
recognize a human protein, but not to recognize the
mouse orthologue. In this situation, a continuous portion
of the human antigen is substituted by the corresponding
mouse sequence, and then, the binding activity to the chi-
mera antigen is analyzed. If the substitution does not
affect, an additional region is substituted again. The
epitope region is narrowed down by repeating the process.
This method works well for continuous epitopes, but can
not narrow down the epitope region enough in case of the
discontinuous ones. Although the chimera proteins
should be designed based on the 3D structure informa-
tion for the monoclonal antibodies which recognize dis-
continuous epitopes, there is no such a tool so far.
In light of this problem, we developed a tool named TCP
(standing for a Tool for designing Chimera Proteins) for
designing chimera proteins based on the tertiary structure
information. It extracts some sets of three mutually
orthogonal cutting surfaces (CSs) for designing chimera
proteins. We believe this algorithm should be a useful tool
for preparing chimera proteins.
Methods
Exploration of CSs with a genetic algorithm
The purpose of this program is the extraction of several
sets of three mutually orthogonal CSs which divide the
target region (TR), e.g. a whole polypeptide or a particular
domain, into two parts. An overview of the algorithm for
searching the CSs is described here. First, the centroid of
the TR's alpha carbons (CAs) is calculated using the coor-
dinates in a protein data bank(PDB) [24,25] file and
appropriate numbers of the first normal vectors for ran-
dom directions, but the coordinate values are integers
between 0 and 63, are generated. Next, a second vector
which is orthogonal to the first vector is generated and the
vector is rotated by appropriate angles. Then, third vectors
which are orthogonal to the first and the second vectors
are generated. Through the process, a series of the second
and the third vectors are obtained for each first vector, and
the three vectors are mutually orthogonal. The TR is
divided into eight portions by a set of the three CSs con-
taining the centroid defined by the three normal vectors.
A reasonable criterion of a good CS set is that the set
divides the TR into even parts. Therefore, we select a pair
of the second and the third vectors which most evenly
divide the TR along with the first vector using the vari-
ances of the number of residues in the eight portions.
Practically, a percentage of the coefficient of variation
(CV) is used instead of the variance, and the CV is defined
as the ratio of the standard deviation to the average.
Next, the generated normal vectors and centroids are opti-
mized by the genetic algorithm (GA) which is a well-
known heuristic method to find exact or approximate
solutions [26]. The first normal vector is encoded as three
6-bit-binary strings and a single recombination is intro-
duced to the fixed number of parents, and the coordinates
of the centroids are swapped between the parents. After
the recombination, mutations are introduced to all genes
except for the individual having highest fitness value at
the 5% of the mutation rate. After the binary to decimal
conversion, the genes are mutated with random number
within appropriate ranges. The mutation with random
numbers is also subjected to the coordinates of the cen-
troid. The ranges are 10 for normal vectors and 1Å for the
centroid at the 5% of the mutation rate. After the manip-
ulations, the individuals are sorted by the fitness values
and fixed population is selected. The inverse of the CV of
the number of residues in the eight portions is used as the
fitness function and maximized. This process is repeated
for proper generations or until satisfying a stopping con-
dition. To avoid the local optima, the whole process is
repeated several times.
Selection of unique CS sets
Although the CS sets are selected based on the even sepa-
ration of the TR, a user would select the suitable CS sets
with more information, e.g. the comparison with the
orthologue, the solvent accessible surface area (ASA) etc.
Therefore, it is better to present several candidates with
different patterns. Here, we define a value, Si,n, which is 1
in case that the n-th CA (CAn) is located on the plane i (Pi)
or at the forward side of Pi, and -1 in case that the CAn is
located at the backward side. The direction is specified by
the normal vector of Pi. Using Si,n, the TR is divided into
two parts. The number of the target residues is denoted as
N, and the pattern vector, Mi, is defined as follows.
After dividing the TR, the divided pattern with the plane is
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defined as follows.
Mi·Mj is the dot product of Mi and Mj. As shown in Figure
1, the more different the separating patterns are, the
Sim(Mi, Mj) value approaches zero. Based on the score,
the newly created plane is evaluated whether it is different
from the already selected ones or not. Although the con-
cept is explained with a single plane case, the pattern vec-
tor is expanded for the combination of three planes. All of
the CS sets which are generated in the selection process are
sorted by the fitness values and the Sim score is evaluated
from top to bottom. If the Sim score is less than a thresh-
old, the CS set is selected as a unique one.
Implementation
TCP was implemented with Perl as a set of three com-
mand-line programs, and outputs the colour-coded
sequences as a rich text file and a set of script files for Ras-
Mol [27,28], which is one of the most popular 3D molec-
ular graphics viewers, to display the colour-coded tertiary
structures (Figure 2, Table 1). In the colour-coding proc-
ess, the result of a DSSP program [29] can be incorpo-
rated. DSSP is a popular program defining the secondary
structures and the ASA from the atomic coordinates in a
PDB file. TCP shows the buried residues in grey based on
a threshold of the ASA calculated by DSSP (Figure 3).
Although the execution time depends on the TR and
parameters, it takes a few minutes under the default con-
dition with a standard PC, such as a 2.4 GHz Pentium 4
processor with a 512 MB RAM. The web interface is also
developed and it is coded with PHP and runs on Linux
and Apache. The colour-coded structures are displayed on
a browser with a Chime plug-in [30] (Figure 4).
Sim P P M M
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The Sim score between two CSsFigure 1
The Sim score between two CSs. It is presumed that a TR has 16 CAs and they are randomly distributed around the cen-
troid (A). The TR is divided by four CSs (P1, P2, P3 and P4) defined by the indicated normal vectors and including the centroid. 
The Si,j values of the CAs are shown in (B). If the TR is divided by two planes and the angle between the normal vectors is zero, 
i.e. P1and P1, the Sim score is Sim(P1,P1) = |-16/16| = 1. Similarly, if the angles between the vectors are π (i.e. P1 and P2), π/2 (i.e. 
P1 and P3) and π/4 (i.e. P1 and P4), the Sim scores are Sim(P1,P2) = |-16/16| = 1, Sim(P1,P3) = |0/16| = 0 and Sim(P1,P4) = |8/16| = 
0.5, respectively.Page 3 of 13
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Exploration of the CS sets with five proteins
At first, human FGF1 was used to test our algorithm and
the PDB identifier is 1EVT. FGF1 is a well-known globular
protein which was originally isolated as a stimulation fac-
tor of fibroblasts [31]. Hereinafter, the polypeptide is
specified as "PDB identifier:Chain". For example, the
notation 1EVT:A means the chain A of 1EVT. Our algo-
rithm found sets of three mutually orthogonal CSs and
the colour-coded figures using one of the CS sets are
shown in Figure 2. This result indicates that the TR was
almost equally divided into two portions by each CS, and
into eight by the combination of the three CSs. To evalu-
ate whether our algorithm is applicable to various shapes
of proteins, it was tested with four other polypeptides,
1EVT:C, 1TNR:A, 1TNR:R and 1YYH:A. As shown in Fig-
ure 5, Table 2 and Table 3, TCP found sets of three CSs
which divided the TRs almost equally into two portions
by each CS and into eight by the combinations. It is note-
worthy that 1EVT:C and 1TNR:R were almost equally
divided in spite of the elongated shapes. Therefore, TCP
should be applicable to various shapes of proteins. The
numbers of residues in the divided portions of 1EVT:A
and 1TNR:R are listed in Table 4. Although the 1EVT:A
was almost equally divided into eight portions by most of
the CS sets, the 1TNR:R was almost equally divided by a
CS set. It indicates that the equal partition of the TR is not
a common result even if the TRs are divided by the mutu-
ally orthogonal three CSs, and the number of the CS sets
which divide the TR equally into eight parts highly
depends on the structures of the TRs.
The performance comparison between the GA-based 
method and the random search
The performance of the GA-based method was compared
with a simple random search (RA) method. The %CV val-
ues of the eight portions divided by the best CS sets and
the execution times are shown in Table 5. The number of
the generating CS sets in the RA-based method was
adjusted with the maximum number of the CS sets in the
GA-based method. As shown in Table 5, the GA-based
method found the better CS sets for all polypeptides in a
short time, and therefore, it overcame the RA-based
method.
The relationship between the Sim score and the number of 
the selected CS sets
We also tested how many CS sets were selected on the five
proteins with various thresholds. As shown in Figure 1,
the rough idea of the angle is obtained from the thresh-
olds by assuming the random distribution of the CAs. The
five thresholds, 0.01, 0.333, 0.5, 0.667 and 0.75, corre-
spond to π/2, π/3, π/4, π/6 and π/8, respectively. Although
zero corresponds to π/2, 0.01 was used instead. Because
the numbers of the target residues were odd number
except for 1TNR:A, the scores of the four proteins were
always greater than zero and only one CS set was selected
if the thresholds was zero. The test was repeated ten times
with the five proteins, and the counts of the selected CS
sets were averaged (Table 6). Interestingly, the threshold
affected the number of the selected CS sets but the differ-
ence of the TR did not. The shapes of the five proteins are
various as described so far, and it means that the shapes of
the TRs do not affect the number of the selected CS sets. It
is a favourable feature because the algorithm is applicable
to various shapes of proteins with the same parameter,
and a universal parameter giving preferable numbers of
the CS sets is adjustable by the Sim score.
Analysis of the antigen-antibody complexes
We show some examples analysing the antigen-antibody
complexes. First, the complexes of the camel antibody
heavy chain fragment (cHC) with the bovine carbonic
anhydrase (bCA) or the chicken egg lysozyme (cEL) were
analyzed (Figure 6). The residues whose CAs are located
within 8 Å of the CAs of the cHC are shown by space fill.
The fourteen residues of bCA, which are in the greenblue
area, are closely located to the cHC (Figure 6A and 6C).
The fourteen residues of the cEL, the thirteen residues of
them are in the pink area and a residue of them is in the
blue one, are closely located to the cHC (Figure 6B and
Table 2: The numbers of residues divided into eight portions by a 
combination of three CSs
Chain R G C M Y P GB B %CV
1EVT:A 17 17 16 16 16 16 17 16 2.96
1EVT:C 21 25 22 25 23 26 23 26 7.39
1TNR:A 17 19 19 17 18 18 18 18 3.93
1TNR:R 18 18 17 17 16 17 18 18 4.01
1YYH:A 24 24 25 25 25 23 23 24 3.24
The colour labels, R, G, C, M, Y, P, GB and B, represent red, green, 
cyan, magenta, yellow, purple, greenblue and blue, respectively. The 
values in the row labelled with 1EVT:A are the actual counts of the 
residues shown in
Table 1: The colour relationship between the combination of the 
three CSs and each CS
Fusion CS1 CS2 CS3
red red red red
green green red red
cyan red green red
magenta green green red
yellow red red green
purple green red green
greenblue red green green
blue green green green
Fusion, CS1, CS2 and CS3 correspond to a, b, c and d of Figure 2, 
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The colour-coded structures of human FGF1Figure 2
The colour-coded structures of human FGF1. The colour-coded tertiary structures (A) and the primary sequences (B) 
of 1EVT:A divided by three CSs. The colour relationship between the eight and the two portions is summarized in Table 1. The 
numbers of residues in the eight and the two parts are shown in Table 2 and Table 3, respectively.
BMC Bioinformatics 2009, 10:9 http://www.biomedcentral.com/1471-2105/10/9
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The use of the solvent accessible surface area (ASA)Figure 3
The use of the solvent accessible surface area (ASA). The colour-coded tertiary structures (A) and the primary 
sequences (B) of 1EVT:A divided with a set of three CSs. The residues having the smaller ASA than the thresholds are col-
oured grey. The ASAs are calculated by DSSP. The result of DSSP is not incorporated in a. The thresholds of the ASAs in b, c 
and d are 0, 10 and 30 Å2 respectively.
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The screenshots of the web interfaceFigure 4
The screenshots of the web interface. The parameter setup screen (A) and the resultant colour-coded structures (B). At 
first, a PDB file and a DSSP file (option) are uploaded to the server. TCP parses the PDB file and the DSSP file, and displays the 
parameter setup menu (A). A user selects the target chain, the target region (TR), etc., and submits the parameters. TCP ana-
lyzes the TR and displays the result in the web-browser (B). The upper part shows the colour-coded 3D structures and the 
primary sequences. By using the web interface, four figures of the TR divided by the combination of the three CSs and each CS 
can be seen at once. The lower part shows the centroids and the normal vectors defining the CSs, and the numbers of residues 
in each part. The set of the CSs can be changed by the pull-down menu. In this example, the target is 1EVT:A and the threshold 
of the ASA is 0 Å2.
BMC Bioinformatics 2009, 10:9 http://www.biomedcentral.com/1471-2105/10/96D). Although the greenblue area of the bCA and the pink
one of the cEL are matched with the interaction surfaces
well, we should note that these are the specific examples
and one or two borders are located in the binding areas in
the most cases. Next, the complex structure of a domain of
the GM-CSF receptor common beta chain (CB) and the
Fab fragment of the monoclonal antibody was analyzed.
As shown in Figure 7, ten amino acid residues of the CB
are closely located to the Fab. These residues disperse to
the three parts, greenblue, yellow and blue, in Figure 7 B-
a (hereinafter, it is represented as B-a), and the interaction
surface includes two borders of the CS sets. In the two-part
designs, these residues belong to the green part in the B-d
and disperse to the both parts in the B-b and the B-c.
Description of the software
TCP has two types of the interface, a stand-alone com-
mand line program and a web-based server-client system.
As shown in Figure 4, TCP displays the colour-coded pri-
mary sequences as the FASTA format and the tertiary struc-
ture images in the web browser. The command-line
program also outputs the results but the primary
sequences are written down in a rich-text file and the ter-
tiary structures are output as the RasMol scripts. A benefit
of the web-interface is that the tertiary structures of the
four designs by a CS set are displayed at once and the
selected CS set can be changed by the pull-down menu.
Most parameters, i.e. the target chain, the target region,
the threshold of the Sim score, the threshold of the ASA,
the background colour, the style and the region to display
the structures, can be set by the user (Figure 4A), and these
parameters are also set in the command-line program as
the command-line arguments. The changes of the target
region and/or the thresholds of the Sim score require the
exploration of the CS sets, and therefore the execution
takes a few minutes. The execution to change the other
parameters, i.e. the threshold of the ASA and the display
parameters of the tertiary structures, is completed in a
moment.
How to use the results
The TCP outputs two types of designs consisting of two
and eight parts. If a set of three designs dividing the TR
into two parts are adopted, six kinds of chimera proteins,
i.e. two for each design, should be prepared (Figure 8). In
this case, the antibody binds three of the six chimera pro-
teins if the antibody does not recognize the borders. If the
antibody recognizes one or two borders, the antibody
binds two or one chimera proteins, respectively. Based on
the binding patterns, the epitope region should be
assigned. If a design dividing the TR into eight parts is
adopted, two methods are considerable. One is the prep-
aration of the eight chimera proteins which contain an
original portion and seven orthologous portions. If an
epitope is located on the borders, the antibody binds
none of the chimera proteins and therefore, the epitope
should not be assigned by this method. Another is the
preparation of the eight chimera proteins which contain
Table 3: The others are the actual counts of them shown in 
Figure 5. Table 3 – The numbers of residues divided into two 
portions with three CSs
Chain CS1 CS2 CS3
R G R G R G
1EVT:A 66 65 66 65 66 65
1EVT:C 89 102 95 96 93 98
1TNR:A 72 72 72 72 72 72
1TNR:R 69 70 69 70 70 69
1YYH:A 97 96 96 97 98 95
The colour labels, R and G, represent red and green, respectively. 
The values in the row labelled with 1EVT:A are the actual counts of 
the residues shown in Figure 2. The others are the actual counts of 
them shown in Figure 5.
Table 4: The partition of 1EVT:A and 1TNR:R with 11 sets of three CSs
Set 1EVT:A 1TNR:R
R G C M Y P GB B %CV R G C M Y P GB B %CV
1 17 17 16 16 16 16 17 16 3.0 18 18 17 17 16 17 18 18 4.0
2 17 17 15 16 16 15 17 18 6.1 17 25 10 19 22 7 21 18 32.7
3 15 17 18 16 17 17 16 15 6.1 7 26 12 26 27 11 26 4 52.7
4 16 18 18 15 17 15 16 16 6.8 16 24 30 2 4 28 22 13 56.6
5 18 16 16 17 16 15 15 18 6.8 31 5 28 16 1 25 8 25 61.9
6 19 16 14 18 17 15 16 16 9.1 26 1 14 30 22 4 8 34 66.8
7 18 17 15 15 15 15 17 19 9.1 6 25 27 12 5 31 32 1 68.4
8 17 19 15 15 14 16 18 17 9.6 30 16 35 3 3 26 1 25 73.0
9 20 15 18 15 15 16 16 16 10.1 30 8 25 5 8 27 0 36 73.0
10 16 15 16 17 16 20 14 17 10.1 31 12 6 30 29 0 1 30 75.3
11 15 16 16 19 18 18 13 16 11.0 10 27 8 33 33 0 28 0 77.2
This table shows the numbers of the residues in the eight portions and the %CV of 1EVT:A and 1TNR:R. The colour representation is described in 
Table 2.Page 8 of 13
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this case, the obtained information is the same from the
three two-part designs, but two more chimera proteins
should be prepared. Therefore, we recommend preparing
the chimera proteins based on each CS and use of the
eight-part design to choose a CS set.
Discussion
There is no doubt about the usefulness of chimera pro-
teins for epitope analysis [21-23] and a simple tool for the
design is required. The usefulness of the chimera proteins
was demonstrated not only for the epitope analysis of the
monoclonal antibodies [22,23] but also for the common
allergen epitopes [21]. We developed TCP as an easy to
use program for the purpose and proved the robustness
using five real protein structures so far. TCP outputs some
sets of four designs, i.e. three two-part designs and an
eight-part design. Users could choose the preferred
designs based on their purposes and prior information.
The application was explained without considering the
location of each residue so far. As shown in Figure 3, the
residues having small ASAs are coloured grey with various
thresholds. The buried residues are less probable to be
parts of the epitope. In addition, substitutions of the bur-
ied residues may break the tertiary structure. Therefore, it
is better to substitute the residues located only at the sur-
face, and the ASA information should be useful for design-
ing the chimera proteins. And then, the information of the
sequence conservation is also useful because the con-
Table 6: The numbers of the selected the CS sets with various 
Sim scores as the thresholds
Chain Thresholds of the Sim score
0.010 0.333 0.500 0.667 0.750 
1EVT:A 2.0 2.9 5.5 11.5 19.4
1EVT:C 2.0 3.0 4.4 12.0 17.7
1TNR:A 1.5 3.4 5.7 11.3 16.7
1TNR:R 1.4 2.4 4.3 11.0 17.2
1YYH:A 1.1 2.1 3.1 6.6 9.9
Average 1.6 2.8 4.6 10.5 16.2
The tests were repeated ten times with various thresholds of the Sim 
scores, and the results were averaged.
The colour-coded tertiary structures of human FGFR1, human TNF-beta, human TNFR-p55 and an ankylin domain of human Notch1Figure 5
The colour-coded tertiary structures of human FGFR1, human TNF-beta, human TNFR-p55 and an ankylin 
domain of human Notch1. A: human FGFR1 (1EVT:C), B: human TNF-beta (1TNR:A), C: human TNFR-p55 (1TNR:R), D: 
an ankylin domain of human Notch1 (1YYH:A). The numbers of the residues in the eight portions are shown in Table 2.
Table 5: A performance comparison of the genetic algorithm 
and the random search
Chain GA Random
%CV Time %CV Time
1EVT:A 3.8 85.4 3.9 239.1
1EVT:C 8.2 168.7 9.2 353.7
1TNR:A 3.6 137.1 8.1 264.2
1TNR:R 3.3 137.3 8.2 254.4
1YYH:A 2.2 167.7 3.6 344.2
Average 4.2 139.2 6.6 291.1
The %CV of the eight portions divided by the best CS set and the 
execution times (seconds) are shown. The tests were repeated ten 
times by a personal computer with a 2.4 GHz Celeron D processor 
and 1,024 Mb RAM, and the results were averaged.Page 9 of 13
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Analysis of the complexes of the camel antibody heavy chain fragment (cHC) with bovine carbonic anhydrase (bCA) or chicken egg ozyme (cEL)Fi ure 6
Analysis of the complexes of the camel antibody heavy chain fragment (cHC) with bovine carbonic anhydrase 
(bCA) or chicken egg lysozyme (cEL). A, B: The complex structures of the cHC with the bCA (A) or the cEL (B). The 
cHC, 1G6V:K in A and 1ZVH:A in B, are coloured white. The bCA (1G6V:A in A) and the cEL (1ZVH:L in B) are coded by 
eight colours. The residues whose CAs are located within 8 Å of the CAs of the antibodies are shown by space fill. C, D: The 
colour-coded amino acid sequences of the bCA (C) and the cEL (D). The residues shown by space fill in A and B are underlined 
in C and D, respectively.
BMC Bioinformatics 2009, 10:9 http://www.biomedcentral.com/1471-2105/10/9served residues could be set aside if the antibody does not
recognize the orthologue. To use such extra information,
the divided patterns by several CS sets should be exam-
ined, and therefore, an appropriate threshold of the Sim
score should be set to reduce the sets to the appropriate
numbers.
Although we used not only single domain polypeptides
but also multi domain ones for the evaluations, the TR is
mostly narrowed down to a single domain by truncations
prior to preparing the chimera proteins, and therefore, a
single domain is generally used as the TR. The majority of
the domains are less than 200 residues [32,33]. If the
epitope region is narrowed down until an eighth part of
the TR using the chimera proteins designed by TCP, the
typical examples are shown in Figure 6, the number of res-
idues in the region is at most 25 residues in many cases.
Furthermore, the number of residues becomes smaller if
the buried residues are set aside. But in many cases, the
epitope regions would include one or two borders, like
Figure 7. Even if the epitope is not narrowed down until
an eighth part, the information that the epitope locates on
the border is obtained. This information is also useful for
the estimation of the epitope region. In the case of Figure
7, the monoclonal antibody would bind one of the chi-
mera proteins based on the Figure 7 B-d (hereinafter, it is
represented as B-d), and would not bind the both chimera
proteins based on the B-b and the B-c. If such results were
Analysis of the complex structure of a domain of the GM-CSF receptor common beta chain (CB) and the Fab fragment of the monoclonal antibodyFigure 7
Analysis of the complex structure of a domain of the GM-CSF receptor common beta chain (CB) and the Fab 
fragment of the monoclonal antibody. A: The complex structure of the CB and the Fab fragment. The heavy chain 
(1EGJ:H) and light chain (1EGJ:L) of the Fab are coloured green and yellow, respectively. The CB (1EGJ:A) is coloured blue and 
the residues whose CAs are located within 8 Å of the CAs of the Fab are coloured red. B: The colour-coded structure of 
1EGJ:A. The black arrow indicates the binding region of the Fab. C: The amino acid sequences of the colour-coded structures 
shown in B. The asterisks indicate the red-coloured residues in A.Page 11 of 13
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in the green portion of the B-d and on the border of the B-
b and the B-c. Because the regions which closely located to
the both borders of the B-b and the B-c are quite restricted
in the green portion of the B-d, the epitope would be
deduced as the quite restricted area. As described with
some examples of the antigen-antibody complex,
epitopes would be narrowed down quite well in many
cases, and we believe the TCP is a useful tool for the anal-
ysis of protein-protein interactions.
Conclusion
We developed TCP, a tool for designing chimera proteins
based on the tertiary structure information. As described
so far, TCP is robust and possesses several favourable fea-
tures. We also showed the results of the analysis of three
different antibody-antigen complexes. These results
should help to imagine the practical use of our program.
In conclusion, we believe TCP is a useful tool for many
experimental scientists.
Availability and requirements
TCP is freely available as Additional file 1 of this manu-
script for academic and non-profit organizations. It
requires Perl and RasMol and runs on Window and Linux
as a set of command-line programs. The web interface
runs on Linux and requires Apache, Perl and PHP for the
server and a Chime plug-in is required for the client.
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The use of chimera proteins divided into two portions for epitope analysisFigure 8
The use of chimera proteins divided into two portions for epitope analysis. A: Projection images of a protein from 
two viewpoints. The lower is the image of that the upper is rotated around the horizontal axis by π/2. Three epitopes are pos-
tulated in the protein and indicated by a filled circle, a filled triangle and a filled box. Three CSs are indicated with a solid line, a 
broken line and a dotted line. B: The six divided portions with the three CSs are labelled with numbers. C: The expected bind-
ing pattern of each epitope indicated in A. A portion with the number shown in B is the original sequence and another is mod-
ified. For example, the area 1 means that the portion 1 is the original sequence and the portion 2 is the substituted sequence. 
It is expected that the antibodies which recognize one of the two epitopes labelled as the filled circle or the filled triangle bind 
the protein labelled as 1, but antibodies which recognize the epitope labelled as the filled box does not.Page 12 of 13
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